FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to thiazolidinedione salts, namely to sodium salt of A compound or potassium salt of compound B .
EFFECT: thiazolidinedione salts, which can be used for treatment and/or prevention of metabolic disorder (for instance, diabetes, obesity or neurodegenerative diseases (for instance, Alzheimer's disease)).
14 dwg, 13 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
DEUTERATED HEPATITIS C PROTEASE INHIBITORS | 2007 |
|
RU2465264C2 |
Authors
Dates
2015-10-10—Published
2010-12-15—Filed